Denys D, de Geus F, van Megen HJ, Westenberg HG (2004), A double-blind, randomized, placebo-controlled trial of quetiapine(Drug information on quetiapine) addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors. J Clin Psychiatry 65(8):1040-1048.
Denys D, van der Wee N, van Megen HJ, Westenberg HG (2003), A double blind comparison of venlafaxine and paroxetine(Drug information on paroxetine) in obsessive-compulsive disorder. J Clin Psychopharmacol 23(6):568-575.
Denys D, van Megen H, Westenberg H (2002), Quetiapine addition to serotonin reuptake inhibitor treatment in patients with treatment-refractory obsessive-compulsive disorder: an open-label study. J Clin Psychiatry 63(8):700-703.
Fallon BA, Liebowitz MR, Campeas R et al. (1998), Intravenous clomipramine(Drug information on clomipramine) for obsessive-compulsive disorder refractory to oral clomipramine: a placebo-controlled study. Arch Gen Psychiatry 55(10):918-924.
Franz B, Bullock K, Elliot M (2001), Oral morphine in treatment resistant OCD. Presented at the Fifth International Obsessive-Compulsive Disorder Conference. Sardinia, Italy; March 29-April 1.
Grady TA, Pigott TA, L'Heureux F et al. (1993), Double-blind study of adjuvant buspirone(Drug information on buspirone) for fluoxetine(Drug information on fluoxetine)-treated patients with obsessive-compulsive disorder. Am J Psychiatry 150(5):819-821.
Greenberg BD, George MS, Martin JD et al. (1997), Effect of prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a preliminary study. Am J Psychiatry 154(6):867-869.
Greist JH, Jefferson JW, Kobak KA et al. (1995), Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis. Arch Gen Psychiatry 52(1):53-60 [see comment].
